Soufiane Boumahdi

Soufiane Boumahdi is a Senior Scientist at iTeos Therapeutics since March 2022, with notable prior experience as a Postdoctoral Researcher at Genentech from June 2017 to September 2021, where significant contributions included the development of in vitro organoid models and pioneering single-cell profiling. Boumahdi completed a PhD in Biomedical Sciences at Université libre de Bruxelles, where research focused on the role of Sox2 in cutaneous squamous cell carcinoma, resulting in impactful publications. Additional experience includes advising several iGEM teams and conducting undergraduate research. Boumahdi holds a Master's degree in Biochemistry and Biotechnologies from INSA Lyon.